Pulmonx Corporation EBITDA Margin 2019-2024 | LUNG
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Pulmonx Corporation (LUNG) over the last 10 years. The current EBITDA margin for Pulmonx Corporation as of September 30, 2024 is .
| Pulmonx Corporation EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $0.08B | $-0.06B | -73.42% |
| 2024-06-30 | $0.08B | $-0.06B | -76.62% |
| 2024-03-31 | $0.07B | $-0.06B | -80.82% |
| 2023-12-31 | $0.07B | $-0.06B | -88.41% |
| 2023-09-30 | $0.07B | $-0.06B | -93.85% |
| 2023-06-30 | $0.06B | $-0.06B | -98.36% |
| 2023-03-31 | $0.06B | $-0.06B | -100.00% |
| 2022-12-31 | $0.05B | $-0.06B | -105.56% |
| 2022-09-30 | $0.05B | $-0.06B | -103.77% |
| 2022-06-30 | $0.05B | $-0.05B | -98.08% |
| 2022-03-31 | $0.05B | $-0.05B | -98.00% |
| 2021-12-31 | $0.05B | $-0.05B | -95.83% |
| 2021-09-30 | $0.04B | $-0.04B | -97.73% |
| 2021-06-30 | $0.04B | $-0.04B | -90.48% |
| 2021-03-31 | $0.03B | $-0.04B | -108.82% |
| 2020-12-31 | $0.03B | $-0.03B | -91.18% |
| 2020-06-30 | $0.02B | $-0.02B | -95.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||